Nrx pharmaceuticals, inc. appoints ira strassberg as chief financial officer and treasurer

Radnor, pa., march 18, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp), a clinical-stage pharmaceutical company, announced today that the company's board of directors appointed ira strassberg as chief financial officer and treasurer effective march 15, 2022.

NRXP Ratings Summary

NRXP Quant Ranking